Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Kristian Jackson

  • Home
  • Author: Kristian Jackson

Customization will spearhead beauty and grooming trends in 2017

Consumers are recognizing the importance of smarter and more connected beauty solutions. These are experiencing a major boom due to the need for tech-validation, alongside the growing desire for more customized beauty offerings that provide unique benefits to each individual consumer, according to GlobalData, a recognized leader in providing business information and analytics.
Read more

Viscosupplementation market in the Middle East and Africa to hit $37 million by 2023

The viscosupplementation space in the Middle East and Africa, which includes the five major markets of Egypt, Israel, Saudi Arabia, South Africa, and the United Arab Emirates, is set to grow from $23.3 million in 2016 to around $37 million by 2023, representing a compound annual growth rate (CAGR) of 4.9%, according to GlobalData, a recognized leader in providing business information and analytics.
Read more

Tauopathies market entry requires shrewd strategies from pharma companies

Pharmaceutical companies hoping to effectively compete in the tauopathies space, which is yet to see its first drug hit the market, are adopting a broad range of strategies including entering into licensing agreements and partnerships for the co-development of products, and pursuing multiple indications and drug candidates, according to GlobalData, a recognized leader in providing business information and analytics.
Read more

Rheumatoid arthritis market will hit $28.5 billion by 2025

The rheumatoid arthritis space across the eight major markets (8MM) of the US, France, Germany, Italy, Spain, the UK, Japan, and Australia, is set to grow from $19.5 billion in 2015 to around $28.5 billion by 2025, representing a compound annual growth rate of 3.9%, according to GlobalData, a recognized leader in providing business information and analytics.
Read more

Tauopathy drugs for neurodegenerative diseases could take off after first-to-market drug is launched

The tauopathies market, which covers more than 20 neurodegenerative diseases such as progressive supranuclear palsy and corticobasal degeneration characterized by tau protein aggregation in the brain, will be driven primarily by the development of novel therapeutics with a first-to-market drug boosting sales and encouraging pharma companies to focus R&D efforts on this market, according to GlobalData, a recognized leader in providing business information and analytics.
Read more

Spirit drinkers keen to experiment with novel flavors but crave authenticity

As global spirit drinkers become more experimental, with at least 39% of them actively trying new varieties within each category, craft distillers are presented with an opportunity to diversify their product portfolio. This can be done by adding unique ingredients, trying unusual ingredient combinations, and using innovative processes, according to GlobalData, a recognized leader in providing business information and analytics.
Read more
1 … 10 11 12 13